GoodRx Holdings, Inc. (GDRX)
- Previous Close
4.2400 - Open
4.2400 - Bid 3.2200 x 200
- Ask 5.4500 x 200
- Day's Range
4.2200 - 4.4650 - 52 Week Range
3.6750 - 9.2600 - Volume
1,835,146 - Avg. Volume
1,608,975 - Market Cap (intraday)
1.552B - Beta (5Y Monthly) 1.25
- PE Ratio (TTM)
108.00 - EPS (TTM)
0.0400 - Earnings Date Aug 6, 2025 - Aug 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
6.39
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solution for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.
www.goodrx.com738
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: GDRX
View More
Performance Overview: GDRX
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GDRX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GDRX
View MoreValuation Measures
Market Cap
1.36B
Enterprise Value
1.46B
Trailing P/E
94.75
Forward P/E
8.96
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.88
Price/Book (mrq)
1.88
Enterprise Value/Revenue
1.84
Enterprise Value/EBITDA
9.47
Financial Highlights
Profitability and Income Statement
Profit Margin
2.07%
Return on Assets (ttm)
3.62%
Return on Equity (ttm)
2.20%
Revenue (ttm)
792.32M
Net Income Avi to Common (ttm)
16.39M
Diluted EPS (ttm)
0.0400
Balance Sheet and Cash Flow
Total Cash (mrq)
448.35M
Total Debt/Equity (mrq)
74.99%
Levered Free Cash Flow (ttm)
116.77M
Research Analysis: GDRX
View MoreResearch Reports: GDRX
View MoreDropping Coverage of GoodRx
GoodRx is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It has over 6 million active monthly users. The company’s primary focus is the U.S. prescription drug market, where GoodRx has developed a price comparison tool that it aggregates from over 200 billion daily pricing data points, directing consumers toward coupons negotiated between a pharmacy and intermediaries (pharmacy benefit managers ). GoodRx generates revenue by taking a small share of the fees paid by pharmacies to PBMs in exchange for routing consumers to these discount programs, and separately through a subscription-based model (GoodRx Gold), which offers discounted drugs to customers paying a monthly membership fee.
Placing GoodRx Under Review
GoodRx is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It has over 6 million active monthly users. The company’s primary focus is the U.S. prescription drug market, where GoodRx has developed a price comparison tool that it aggregates from over 200 billion daily pricing data points, directing consumers toward coupons negotiated between a pharmacy and intermediaries (pharmacy benefit managers ). GoodRx generates revenue by taking a small share of the fees paid by pharmacies to PBMs in exchange for routing consumers to these discount programs, and separately through a subscription-based model (GoodRx Gold), which offers discounted drugs to customers paying a monthly membership fee.
RatingPrice TargetGoodRx Shares Tumble After Full-Year Guidance Pulled on News of Grocer-PBMs Dispute
GoodRx is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It has over 6 million active monthly users. The company’s primary focus is the U.S. prescription drug market, where GoodRx has developed a price comparison tool that it aggregates from over 200 billion daily pricing data points, directing consumers toward coupons negotiated between a pharmacy and intermediaries (pharmacy benefit managers ). GoodRx generates revenue by taking a small share of the fees paid by pharmacies to PBMs in exchange for routing consumers to these discount programs, and separately through a subscription-based model (GoodRx Gold), which offers discounted drugs to customers paying a monthly membership fee.
RatingPrice TargetGoodRx Shares Tumble After Full-Year Guidance Pulled on News of Grocer-PBMs Dispute
GoodRx is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It has over 6 million active monthly users. The company’s primary focus is the U.S. prescription drug market, where GoodRx has developed a price comparison tool that it aggregates from over 200 billion daily pricing data points, directing consumers toward coupons negotiated between a pharmacy and intermediaries (pharmacy benefit managers ). GoodRx generates revenue by taking a small share of the fees paid by pharmacies to PBMs in exchange for routing consumers to these discount programs, and separately through a subscription-based model (GoodRx Gold), which offers discounted drugs to customers paying a monthly membership fee.
RatingPrice Target